Search research articles
Contact Us
Filters
Showing results (21-30 of 47) with videos related to
Page
of 5
Sort By:
Psychiatry Research
|
October 19, 2004
Brief emotion training improves recognition of facial emotions in chronic schizophrenia. A pilot study
Henry Silver, Craig Goodman, Gabriela Knoll, et al.
Comprehensive Psychiatry
|
September 24, 2005
Insight into illness in schizophrenia
Craig Goodman, Gabriella Knoll, Victoria Isakov, et al.
Current Medicinal Chemistry
|
November 20, 2012
The role of GABA-A receptor in the synergism between SSRI and antipsychotic in schizophrenia; implications for antipsychotic modes of actions
Henry Silver, Reef Einoch, Moussa Youdim, et al.
Schizophrenia Research
|
April 17, 2002
Perception of happy and sad facial expressions in chronic schizophrenia: evidence for two evaluative systems
Henry Silver, Nili Shlomo, Travis Turner, et al.
The American Journal of Psychiatry
|
September 30, 2003
Working memory deficit as a core neuropsychological dysfunction in schizophrenia
Henry Silver, Pablo Feldman, Warren Bilker, et al.
International Clinical Psychopharmacology
|
September 30, 2005
A double-blind, cross-over comparison of the effects of amantadine or placebo on visuomotor and cognitive function in medicated schizophrenia patients
Henry Silver, Craig Goodman, Victoria Isakov, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
December 27, 2008
Multifunctional pharmacotherapy: what can we learn from study of selective serotonin reuptake inhibitor augmentation of antipsychotics in negative-symptom schizophrenia?
Henry Silver, Yael Chertkow, Orly Weinreb, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
July 31, 2007
Gene expression changes in peripheral mononuclear cells from schizophrenic patients treated with a combination of antipsychotic with fluvoxamine
Yael Chertkow, Orly Weinreb, Moussa B H Youdim, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
July 7, 2009
Molecular mechanisms underlying synergistic effects of SSRI-antipsychotic augmentation in treatment of negative symptoms in schizophrenia
Yael Chertkow, Orly Weinreb, Moussa B H Youdim, et al.
The International Journal of Neuropsychopharmacology
|
February 26, 2010
The involvement of GABA(A) receptor in the molecular mechanisms of combined selective serotonin reuptake inhibitor-antipsychotic treatment
Lena Danovich, Orly Weinreb, Moussa B H Youdim, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 47) with videos related to
Sort By:
Page
of 5
Psychiatry Research
|
October 19, 2004
Brief emotion training improves recognition of facial emotions in chronic schizophrenia. A pilot study
Henry Silver, Craig Goodman, Gabriela Knoll, et al.
Comprehensive Psychiatry
|
September 24, 2005
Insight into illness in schizophrenia
Craig Goodman, Gabriella Knoll, Victoria Isakov, et al.
Current Medicinal Chemistry
|
November 20, 2012
The role of GABA-A receptor in the synergism between SSRI and antipsychotic in schizophrenia; implications for antipsychotic modes of actions
Henry Silver, Reef Einoch, Moussa Youdim, et al.
Schizophrenia Research
|
April 17, 2002
Perception of happy and sad facial expressions in chronic schizophrenia: evidence for two evaluative systems
Henry Silver, Nili Shlomo, Travis Turner, et al.
The American Journal of Psychiatry
|
September 30, 2003
Working memory deficit as a core neuropsychological dysfunction in schizophrenia
Henry Silver, Pablo Feldman, Warren Bilker, et al.
International Clinical Psychopharmacology
|
September 30, 2005
A double-blind, cross-over comparison of the effects of amantadine or placebo on visuomotor and cognitive function in medicated schizophrenia patients
Henry Silver, Craig Goodman, Victoria Isakov, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
December 27, 2008
Multifunctional pharmacotherapy: what can we learn from study of selective serotonin reuptake inhibitor augmentation of antipsychotics in negative-symptom schizophrenia?
Henry Silver, Yael Chertkow, Orly Weinreb, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
July 31, 2007
Gene expression changes in peripheral mononuclear cells from schizophrenic patients treated with a combination of antipsychotic with fluvoxamine
Yael Chertkow, Orly Weinreb, Moussa B H Youdim, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
July 7, 2009
Molecular mechanisms underlying synergistic effects of SSRI-antipsychotic augmentation in treatment of negative symptoms in schizophrenia
Yael Chertkow, Orly Weinreb, Moussa B H Youdim, et al.
The International Journal of Neuropsychopharmacology
|
February 26, 2010
The involvement of GABA(A) receptor in the molecular mechanisms of combined selective serotonin reuptake inhibitor-antipsychotic treatment
Lena Danovich, Orly Weinreb, Moussa B H Youdim, et al.
Page
of 5